Ironwood Pharmaceuticals | IRWD - 資産





資産 変化する 日付
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Almirall EUR 2.34B 29.21M 2025-12
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Amarin USD 645.76M 25.01M 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Charles River Laboratories USD 7.14B 378.39M 2025-12
Coherus Biosciences USD 258.34M 258.18M 2025-12
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Incyte USD 7.34B 381.14M 2026-03
Ironwood Pharmaceuticals USD 396.06M 53.12M 2025-09
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Lexicon Pharmaceuticals USD 184.99M 20.94M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Moderna USD 11.49B 850M 2026-03
Myriad Genetics USD 706.6M 21.5M 2025-12
Pacira USD 1.21B 56.38M 2026-03
PTC Therapeutics USD 2.9B 255.07M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Takeda JPY 15.41T 938.47B 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12